image
Healthcare - Biotechnology - NASDAQ - US
$ 22.04
-0.136 %
$ 3.74 B
Market Cap
-9.97
P/E
IMVT - STOCK-BASED COMPENSATION

Stock-based Compensation IMVT - Immunovant, Inc.

image
41.1 M
LAST VALUE
9.58%
2 YEAR CAGR
99.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR